Biomimetic magnetobacterial microrobots for active pneumonia therapy.

Journal: Nature communications
Published Date:

Abstract

Immense progress in synthetic micro-/nanorobots with diverse functionalities has been made for biomedical applications during the last decade. However, there is still a huge gap for miniature robots to realize efficient therapy from in vitro to in vivo level. Here click chemistry is used to introduce curcumin-loaded hybrid cell membrane nanoparticles to magnetotactic bacteria AMB-1 with magnetic actuation, thus creating biohybrid microrobots CurNPs@2TM-AMB-1 for active and efficient pneumonia therapy in vivo. In the presence of an external rotating magnetic field, the developed AR are capable of moving controllably and wirelessly, and efficiently scavenging inflammatory factors and SARS-CoV-2 pseudovirus due to the existing receptors from the cell membrane cloaking strategy, thereby inhibiting the virus invasion and reducing the damage of inflammation to the lungs. Due to the active movement, AR significantly increase and prolong the accumulation of Cur in the lungs in vivo, thus alleviating the pneumonia and regulating pneumonia microenvironment. The designed hybrid microrobot system, with magnetic actuation and active neutralization of inflammatory factors and virus, shows great promise as a potential platform for pneumonia therapy.

Authors

  • Lishan Zhang
    Fujian Provincial Key Laboratory of Agroecological Processing and Safety Monitoring (School of Life Sciences, Fujian Agriculture and Forestry University), Fuzhou 350002, China.
  • Ze Chen
    Department of Neurology, Xijing Hospital, Air Force Medical University, Xi'an, PR China. Electronic address: chenz_e@126.com.
  • Hui Ran
    Guangdong Key Laboratory of Nanomedicine, CAS-HK Joint Lab of Biomaterials, Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences, Shenzhen 518055, PR China; Guangdong Key Laboratory for Research and Development of Natural Drugs, Key Laboratory for Nanomedicine, Guangdong Medical University, Dongguan 523808, PR China.
  • Mirai Azechi
    NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
  • Xue Yang
    Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, China.
  • Weichang Huang
    NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
  • Hao Tian
    Institute of Medicinal Plants, Yunnan Academy of Agricultural Sciences, Kunming 650200, China; Yunnan Technical Center for Quality of Chinese Materia Medica, Kunming 650200, China.
  • Lihan Shen
    Department of Critical Care Medicine, Dongguan Institute of Respiratory and Critical Care Medicine, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, China. shenlihan@hotmail.com.
  • Fei Peng
    College of Food Science and Engineering, Northwest A&F University, Yangling 712100, China.
  • Yingfeng Tu
    Harbin Medical University, Harbin, China; Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin 150000, China; Department of Cardiology, The Shanxi Provincial People's Hospital, Taiyuan 030000, China. Electronic address: tyfdoctor@163.com.